Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Gene therapy encompasses a spectrum of therapeutic strategies, ranging from the compelling concept of using wild type copies of genes to correct the root cause of recessive genetic disorders through to using genes to mediate powerful and selective toxicity to cancer cells. Inspirational for the general public as well as the bioscience community, gene therapy has been grabbing the headlines--for good and bad reasons--regularly for the past 15 years. In this personal appraisal, Professor Len Seymour assesses the progress of gene therapy in the UK and what it might deliver in the foreseeable future.

Original publication

DOI

10.1016/j.tibtech.2006.06.002

Type

Journal article

Journal

Trends Biotechnol

Publication Date

08/2006

Volume

24

Pages

347 - 349

Keywords

Biotechnology, Clinical Trials as Topic, Drug Industry, Forecasting, Gene Transfer Techniques, Genetic Engineering, Genetic Therapy, United Kingdom